Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical/Finance 202 AGARWAL PLAZA PLOT NO 3 DDA COMPLEX SECTOR 14 PRASHANT VIHAR ROHINI 85 NEW DELHI DELHI INDIA 110085 | NEW DELHI | NORTH WEST DELHI | DELHI | 110085 | Admitted-Fee/PreQual/Technical/Finance |
| 2 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
| 3 | Admitted-Fee/PreQual/Technical/Finance C 21 22 23 SECTOR 3 NOIDA 201301 DIST GAUTAM BUDH NAGAR U P | NOIDA | GAUTAM BUDH NAGAR | UTTAR PRADESH | 201301 | Admitted-Fee/PreQual/Technical/Finance |
Tender Value
₹1.5 Cr
Closing Date
22 May 2025, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MD, AMSCL
AMSCL
Supply of essential 12 drugs
2025_HFWD_44367_1
Essential Drugs 12 nos 19-05-2025
Limited
Medicines
Supply
75 days
AMSCL
Please refer Tender documents.
1 document required · 1 mandatory
₹0
Exempted
22 May 2025
19 May 2025
22 May 2025
19 May 2025
22 May 2025
19 May 2025
3FDC(P) (H50, R75, Z150) [DSTB-IP(P)(Isoniazid IP 50 mg(H) + Rifampicin IP 75 mg(R) + Tab Pyrazinamide IP 150mg(Z))Each FDC tablet contains:- Isoniazid IP 50 mg(H) + Rifampicin IP 75 mg(R) + Tab Pyrazinamide IP 150mg(Z) & Specification as per Annexure-A of the referred tender no. E-630176/12371, dated 18.03.2025.
2FDC (P) (H50 & R75) [DSTB-CP(P)Each FDC tablet contains:- Isoniazid IP 50 mg (H) + Rifampicin IP 75 mg (R ) & Specification as per Annexure-B, of the referred tender no. E-630176/12371, dated 18.03.2025.
Cycloserine Each Capsule contain:- Cycloserine 250 mg & Specification as per Annexure-D, of the referred tender no. E-630176/12371, dated 18.03.2025.
Ethambutol Each Tablet contain:- Ethambutol Hydrochloride 100 mg & Specification as per Annexure-E, of the referred tender no. E-630176/12371, dated 18.03.2025.
Ethambutol Each Tablet contain:- Ethambutol Hydrochloride 400mg & Specification as per Annexure-F, of the referred tenderno. E-630176/12371, dated 18.03.2025.
Ethambutol Each Tablet contain:- Ethambutol Hydrochloride 800mg & Specification as per Annexure-G, of the referred tenderno. E-630176/12371, dated 18.03.2025.
Isoniazid Each Tablet contain:- Isoniazid 300mg & Specification as per Annexure-H,of the referred tenderno. E-630176/12371, dated 18.03.2025.
Levofloxacin Each Tablet contain:- Levofloxacin 250 mg & Specification as per Annexure-I, of the referred tenderno. E-630176/12371, dated 18.03.2025.
Pyrazinamide Each Tablet contain:- Pyrazinamide 500mg & Specification as per Annexure-J, of the referred tenderno. E-630176/12371, dated 18.03.2025.
Pyrazinamide Each Tablet contain:- Pyrazinamide 750mg & Specification as per Annexure-K, of the referred tenderno. E-630176/12371, dated 18.03.2025.
Pyridoxine Each Tablet contain:- Pyridoxine Hydrochloride 100 mg & Specification as per Annexure-L, of the referred tenderno. E-630176/12371, dated 18.03.2025.
Rifampicin Each Tablet/ Capsule contain:- Rifampicin 300mg & Specification as per Annexure-N, of the referred tenderno. E-630176/12371, dated 18.03.2025.
stage.html
html • 0.02 MB
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .